Bluebird Stock Reverses Gains, Down Nearly 12%

The biotech company is in focus after the FDA approved SKYSONA

Deputy Editor
Sep 19, 2022 at 10:32 AM
facebook X logo linkedin


Bluebird Bio Inc (NASDAQ:BLUE) is in the spotlight today, after the U.S. Food and Drug Administration (FDA) approved SKYSONA, its gene therapy for the treatment of Cerebral Adrenoleukodystrophy (CALD) -- a rare neurological disorder found in children's brains ages three to 12. BLUE has pulled back from its premarket surge, however, down 11.9% at $5.58 at last glance. The stock is on the Short Sell Restricted (SSR) list amid the broad market volatility.

Though today's drop now has Bluebird stock at its lowest level since late August, the $5.50 level, which coincides with the 60-day moving average, still lingers below as support. Year-to-date, the equity is down 42.7%. 

Options bulls are on the hunt already this morning, with 5,647 calls exchanged so far -- three times the intraday average. The October 7.50 call is the most popular, followed by the 5 call in the same monthly series. 

This bullish sentiment has held true for the past 10 weeks. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), BLUE sports a 50-day call/put volume ratio of 15.92, which stands higher than 94% of readings from the past year. Given a healthy 25% of BLUE's total available float is sold short, its possible some of this call bias could be shorts seeking an options hedge.

 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI